NCT05432674

Brief Summary

The Digital Fall Prevention Study is a single-group unblinded study to explore the feasibility and acceptability of a 3-month fall prevention exercise program delivered digitally via a tablet interface. Evidence-based exercise programs and motivational techniques will be used along with new wearable technology to predict fall risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 27, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

June 30, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

June 17, 2022

Last Update Submit

July 25, 2023

Conditions

Keywords

exercisefall prevention

Outcome Measures

Primary Outcomes (5)

  • Acceptability and adherence to exercise program

    Percentage of scheduled exercise sessions complete (70% of sessions completed = acceptable adherence)

    over the 12 weeks of the intervention

  • Feasibility of Intervention Measure (FIM)

    a self-report measure of the intervention feasibility, score range is 1-5, higher score = greater feasibility

    at final (12-week) assessment

  • Acceptability of Intervention Measure (AIM)

    a self-report measure of acceptability of the intervention, score range is 1-5, higher score = greater acceptability

    at final (12-week) assessment

  • Fall Efficacy Scale - International (FES-I)

    fear of falling measure, score range from 16-64, higher score=less fear of falling

    change from baseline to 12-weeks

  • Intervention Appropriateness Measure (IAM)

    a self-report measure of the intervention appropriateness, score range is 1-5, higher score = greater appropriateness

    at final (12-week) assessment

Secondary Outcomes (9)

  • Montreal Cognitive Assessment (MoCA)

    change from baseline to 12-weeks

  • Digit Symbol Substitution Test

    change from baseline to 12-weeks

  • Fried Frailty Index (FFI)

    change from baseline to 12-weeks

  • Grip Strength of dominant hand

    change from baseline to 12-weeks

  • Physical Activity Scale for the Elderly (PASE)

    change from baseline to 12-weeks

  • +4 more secondary outcomes

Study Arms (1)

Digital Fall Prevention

EXPERIMENTAL

Subjects will participate in Digital Fall Prevention intervention for 12 weeks

Combination Product: Digital Fall Prevention

Interventions

Digital Fall PreventionCOMBINATION_PRODUCT

Exercises delivered through a tablet and remote motivational calls

Digital Fall Prevention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Male and females who are 65 years or older
  • Short Physical Performance Battery (SPPB)7 ≥ 5
  • the Montreal Cognitive Assessment (MoCA)8 \> 17
  • Increased risk for falls based on a self-reported answer of yes to one or more of these questions:
  • Have you fallen and hurt yourself in the past year?
  • Have you fallen two or more times in the past year?
  • Are you afraid that you might fall because of balance or walking problems?
  • Access to Wi-Fi in their home (or willingness to use cellular service if provided)

You may not qualify if:

  • Unable or unwilling to provide informed consent
  • MI, acute coronary syndrome, revascularization surgery, or stroke in the last 6 months
  • Chest pain or untreated/uncontrolled CVD
  • Hip/knee fracture/replacement or spinal surgery in past 6 months
  • Pulmonary decompensation that would prevent participation in the exercise program
  • Planned orthopedic surgery that would limit participation in the study
  • Planned to be away from tablet access for \> 7 days during the length of the study
  • Unable to attend in-person pre- or post-study clinic visit
  • Enrolled in a formal exercise program and/or physical therapy that takes place 3 or more times per week
  • Vision or hearing impairments that would make it difficult to participate in the intervention
  • Non-English speaking or other language limitations that would make it difficult to participate in the intervention
  • Reside in a nursing home
  • Unable to walk independently (with or without a walking aid)
  • Not appropriate for study based on clinician exam or discretion (clinician will specify reason)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Kieran F Reid, PhD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Director, Research Division of Men's Health, Aging and Metabolism

Study Record Dates

First Submitted

June 17, 2022

First Posted

June 27, 2022

Study Start

June 30, 2022

Primary Completion

May 25, 2023

Study Completion

June 1, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations